New paradigm in the way glaucoma is diagnosed

Article

Suggesting a change in the way physicians diagnose glaucoma, Robert Weinreb, MD, outlined a new paradigm for diagnosis of the disease in his Glaucoma Society of International Ophthalmology Congress (GCIOC) Day Lecture, presented Monday at the World Ophthalmology Congress. Dr. Weinreb said that the glaucoma field is undergoing a revolution in diagnosis. He said there is a transition from reliance solely on visual fields to the increased use of structural analysis of the optic disk and RNFL. "It's something that was initiated 20 years ago," explained Dr. Weinreb. "Changes are very, very slow in glaucoma, as it does in all medical disciplines. We have reached an infliction point in glaucoma diagnosis where we are about to reap the benefits of this revolution."

Suggesting a change in the way physicians diagnose glaucoma, Robert Weinreb, MD, outlined a new paradigm for diagnosis of the disease in his Glaucoma Society of International Ophthalmology Congress (GCIOC) Day Lecture, presented Monday at the World Ophthalmology Congress.

Dr. Weinreb said that the glaucoma field is undergoing a revolution in diagnosis. He said there is a transition from reliance solely on visual fields to the increased use of structural analysis of the optic disk and RNFL.

"It's something that was initiated 20 years ago," explained Dr. Weinreb. "Changes are very, very slow in glaucoma, as it does in all medical disciplines. We have reached an infliction point in glaucoma diagnosis where we are about to reap the benefits of this revolution."

Dr. Weinreb, director of the Hamilton Glaucoma Center at the University of California, San Diego, proceed to discuss the diagnosis of glaucoma. Citing that glaucoma is a continuum where a patient progresses from a non-detectable disease to asystematic disease, glaucoma is detected by a change in visual function or change in the appearance of the optic disk or RNFL.

The number of patients who have glaucoma worldwide is not really known, Dr. Weinreb pointed out. It's estimated that between 70 million to 100 million people have glaucoma. "The key point is that at least half of the patients with glaucoma are not recognized. Between 90% to 95% who have glaucoma don't know they have glaucoma, and have not yet been diagnosed with it."

He then reviewed the standard by which glaucoma is currently detected, including the assessment of standard visual field and standard automatic perimetry, with years of long follow-up periods to monitor the progression of glaucoma in patients.

Dr. Weinreb explained that the paradigm for glaucoma diagnosis and the changing concept would center on the assessments of the optic disk and RNFL along with visual function. They will be essential elements to quality glaucoma diagnosis.

"Glaucoma can be defined as a common structural or structural-functional abnormality," Dr. Weinreb said. "Glaucoma can also be defined as a progressive structural or functional change, such as the progressive change in the disk, RNFL, or the visual field. That's probably the most specific diagnosis for glaucoma."

He concluded that slight functional testing complements standard automated perimetry and facilitates the earlier diagnosis. The evaluation of the documentation of the optic disk and the RNFL enhance glaucoma diagnosis. Structural and functional testing provides complementary information for sensitive and specific glaucoma diagnosis.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
© 2025 MJH Life Sciences

All rights reserved.